ÐÇ¿ÕÊÓÆµ

Disclosure UK

Disclosure UK

The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and deliveryÌýof life-enhancing and life-saving medicines.Ìý

It is a relationship thatÌýwe are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and othersÌýhave confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and otherÌýbenefits in kindÌýmade by industry to HCPs and HCOs.

This information will be published on theÌýdatabase - Disclosure​ UK.Ìý

Disclosure UK database

Ìý

Disclosure UK is part of aÌýÌýto increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals andÌýorganisations it works with.

Explore the data further

As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.

2026 timeline for 2025 disclosure data

For pharmaceutical companies abiding by the ÐÇ¿ÕÊÓÆµ Code of Practice

HCP and Hospital icons

Full disclosures about healthcare professionals, other relevant decision makers, and healthcare organisations must be submitted to Disclosure UK by:

14:00 BST, Tuesday 31 March 2026

Data submission deadline

Purple arrow right

Ribbon

Gateway links to disclosure information about patient organisations and members of the public must be submitted to Disclosure UK by:

Tuesday 23 June 2026

Gateway links submission deadline

Purple arrow right

Globe

Disclosure data and links submitted for 2025 will be published together at the end of June:


Tuesday 30 June 2026

Publication

See also, the ÐÇ¿ÕÊÓÆµ Code of Practice and supplementary information to clause 31.1 regarding disclosure timelines.

Pfizer Doctor

European Disclosure Gateway

To improve access to European data, the pharmaceutical industry has voluntarily created this single point of access to help any interested stakeholder navigate the publicly available data across all EFPIA Members countries whether hosted on individual company websites or centralised on national platforms.

Ìý

Disclosure UK publications